Reduction in insomnia symptoms associated with non-invasive neurotechnology

WINSTON-SALEM, N.C. — September 17, 2020 — For people with chronic insomnia, a good night’s sleep is elusive. But what if insomnia symptoms could be alleviated by simply listening to one’s own brainwaves? Researchers at Wake Forest Baptist Health conducted a clinical trial that showed reduced insomnia symptoms and improved autonomic nervous system function using…

Details

New virtual screening tool eases, accelerates routine diagnosis of pulmonary hypertension

(Philadelphia, PA) – The COVID-19 pandemic has increasing numbers of doctors caring for patients virtually. While critical to protecting patient health during a pandemic, however, virtual care presents unique challenges, especially when it comes to diagnosis. Now, cardiologists at the Lewis Katz School of Medicine at Temple University (LKSOM), have come up with a virtual…

Details

The acrobatic hydra shows off: How environmental cues can affect behavior

WOODS HOLE, Mass. — Although it may seem counterintuitive, researchers are turning to an animal without a brain to crack the neural code underlying behavior. Hydra vulgaris, a tiny, tentacled, freshwater organism, uses “nets” of neurons dispersed throughout its tube-like body to coordinate stretching, contracting, somersaulting, and feeding movements. This simple nervous system is one…

Details

Morris Animal Foundation awards nearly $1M in grants for new studies for equine health

Morris Animal Foundation, a leader in advancing animal health, has awarded nearly $1 million in large animal health research grants, supporting 14 projects. The studies will help veterinary scientists improve the well-being of horses through improved prevention and treatment of numerous health challenges, including eye cancer, heart arrhythmias and risks for injury from air transport.…

Details

Imaging probe to visualize Alzheimer’s disease-related gamma-secretase in the brain

BOSTON – Scientists at the Massachusetts General Hospital (MGH) have developed a molecular imaging probe to reveal Alzheimer’s disease (AD)-related γ-secretase in rodents and macaques with translational potentials in humans. γ-Secretase is a key player in the etiology of AD and a prime drug target for AD, whose brain regional expression and distribution have yet…

Details

C-Path launches consortium to support medical product development in sickle cell disease

TUCSON, Ariz., Sept. 17, 2020 — The Critical Path Institute (C-Path) today announced the launch of the Critical Path for Sickle Cell Disease (CP-SCD) Consortium to support collaboration and regulatory endorsement of new medical product development tools for sickle cell disease. These tools will help to optimize and de-risk clinical trials to increase efficiency in…

Details